dlr assay system kit Search Results


dlr assay system kit  (Promega)
90
Promega dlr assay system kit
Dlr Assay System Kit, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dlr assay system kit/product/Promega
Average 90 stars, based on 1 article reviews
dlr assay system kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
dlr system  (Promega)
90
Promega dlr system
Dlr System, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dlr system/product/Promega
Average 90 stars, based on 1 article reviews
dlr system - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
dlr 100 kit  (Promega)
90
Promega dlr 100 kit
Dlr 100 Kit, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dlr 100 kit/product/Promega
Average 90 stars, based on 1 article reviews
dlr 100 kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
dlr assay kit  (Beijing Solarbio Science)
90
Beijing Solarbio Science dlr assay kit
miR-98-5p is a target of CDKN2B-AS1. A: The common miRNA binding sites on CDKN2B-AS1 predicted by starBase and lncRBase; B: Subcellular localization of CDKN2B-AS1 detected by FISH assay (400×); C: miR-98-5p binding sites on CDKN2B-AS1; D: <t>DLR</t> assay results; E: RIP assay results; F: Expression levels of miR-98-5p in various tumors; G: Expression levels of miR-98-tp in the NPC tissues (n=38); H: ROC curve of miR-98-5p in the diagnosis of NPC; I: Correlation between the expression level of CDKN2B-AS1 and the expression level of miR-98-5p; J: Expression of miR-98-5p in the NPC cell line; K: Expression level of miR-980tp in NPC. Compared with the NP69 cell line, *P<0.05. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; FISH: fluorescence in situ hybridization; <t>DLR:</t> <t>dual-luciferase</t> reporter; RIP: RNA immunoprecipitation.
Dlr Assay Kit, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dlr assay kit/product/Beijing Solarbio Science
Average 90 stars, based on 1 article reviews
dlr assay kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
dlr gene detection kit  (Beijing Solarbio Science)
90
Beijing Solarbio Science dlr gene detection kit
miR-98-5p is a target of CDKN2B-AS1. A: The common miRNA binding sites on CDKN2B-AS1 predicted by starBase and lncRBase; B: Subcellular localization of CDKN2B-AS1 detected by FISH assay (400×); C: miR-98-5p binding sites on CDKN2B-AS1; D: <t>DLR</t> assay results; E: RIP assay results; F: Expression levels of miR-98-5p in various tumors; G: Expression levels of miR-98-tp in the NPC tissues (n=38); H: ROC curve of miR-98-5p in the diagnosis of NPC; I: Correlation between the expression level of CDKN2B-AS1 and the expression level of miR-98-5p; J: Expression of miR-98-5p in the NPC cell line; K: Expression level of miR-980tp in NPC. Compared with the NP69 cell line, *P<0.05. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; FISH: fluorescence in situ hybridization; <t>DLR:</t> <t>dual-luciferase</t> reporter; RIP: RNA immunoprecipitation.
Dlr Gene Detection Kit, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dlr gene detection kit/product/Beijing Solarbio Science
Average 90 stars, based on 1 article reviews
dlr gene detection kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
larii reagent of dlr-kit  (Promega)
90
Promega larii reagent of dlr-kit
miR-98-5p is a target of CDKN2B-AS1. A: The common miRNA binding sites on CDKN2B-AS1 predicted by starBase and lncRBase; B: Subcellular localization of CDKN2B-AS1 detected by FISH assay (400×); C: miR-98-5p binding sites on CDKN2B-AS1; D: <t>DLR</t> assay results; E: RIP assay results; F: Expression levels of miR-98-5p in various tumors; G: Expression levels of miR-98-tp in the NPC tissues (n=38); H: ROC curve of miR-98-5p in the diagnosis of NPC; I: Correlation between the expression level of CDKN2B-AS1 and the expression level of miR-98-5p; J: Expression of miR-98-5p in the NPC cell line; K: Expression level of miR-980tp in NPC. Compared with the NP69 cell line, *P<0.05. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; FISH: fluorescence in situ hybridization; <t>DLR:</t> <t>dual-luciferase</t> reporter; RIP: RNA immunoprecipitation.
Larii Reagent Of Dlr Kit, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/larii reagent of dlr-kit/product/Promega
Average 90 stars, based on 1 article reviews
larii reagent of dlr-kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
dual-luciferase reporter assay kit dlr 1000  (Promega)
90
Promega dual-luciferase reporter assay kit dlr 1000
miR-98-5p is a target of CDKN2B-AS1. A: The common miRNA binding sites on CDKN2B-AS1 predicted by starBase and lncRBase; B: Subcellular localization of CDKN2B-AS1 detected by FISH assay (400×); C: miR-98-5p binding sites on CDKN2B-AS1; D: <t>DLR</t> assay results; E: RIP assay results; F: Expression levels of miR-98-5p in various tumors; G: Expression levels of miR-98-tp in the NPC tissues (n=38); H: ROC curve of miR-98-5p in the diagnosis of NPC; I: Correlation between the expression level of CDKN2B-AS1 and the expression level of miR-98-5p; J: Expression of miR-98-5p in the NPC cell line; K: Expression level of miR-980tp in NPC. Compared with the NP69 cell line, *P<0.05. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; FISH: fluorescence in situ hybridization; <t>DLR:</t> <t>dual-luciferase</t> reporter; RIP: RNA immunoprecipitation.
Dual Luciferase Reporter Assay Kit Dlr 1000, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dual-luciferase reporter assay kit dlr 1000/product/Promega
Average 90 stars, based on 1 article reviews
dual-luciferase reporter assay kit dlr 1000 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
passive lysis buffer promega dlr-kit  (Promega)
90
Promega passive lysis buffer promega dlr-kit
miR-98-5p is a target of CDKN2B-AS1. A: The common miRNA binding sites on CDKN2B-AS1 predicted by starBase and lncRBase; B: Subcellular localization of CDKN2B-AS1 detected by FISH assay (400×); C: miR-98-5p binding sites on CDKN2B-AS1; D: <t>DLR</t> assay results; E: RIP assay results; F: Expression levels of miR-98-5p in various tumors; G: Expression levels of miR-98-tp in the NPC tissues (n=38); H: ROC curve of miR-98-5p in the diagnosis of NPC; I: Correlation between the expression level of CDKN2B-AS1 and the expression level of miR-98-5p; J: Expression of miR-98-5p in the NPC cell line; K: Expression level of miR-980tp in NPC. Compared with the NP69 cell line, *P<0.05. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; FISH: fluorescence in situ hybridization; <t>DLR:</t> <t>dual-luciferase</t> reporter; RIP: RNA immunoprecipitation.
Passive Lysis Buffer Promega Dlr Kit, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/passive lysis buffer promega dlr-kit/product/Promega
Average 90 stars, based on 1 article reviews
passive lysis buffer promega dlr-kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
dlr gene determination kit  (Beijing Solarbio Science)
90
Beijing Solarbio Science dlr gene determination kit
miR-98-5p is a target of CDKN2B-AS1. A: The common miRNA binding sites on CDKN2B-AS1 predicted by starBase and lncRBase; B: Subcellular localization of CDKN2B-AS1 detected by FISH assay (400×); C: miR-98-5p binding sites on CDKN2B-AS1; D: <t>DLR</t> assay results; E: RIP assay results; F: Expression levels of miR-98-5p in various tumors; G: Expression levels of miR-98-tp in the NPC tissues (n=38); H: ROC curve of miR-98-5p in the diagnosis of NPC; I: Correlation between the expression level of CDKN2B-AS1 and the expression level of miR-98-5p; J: Expression of miR-98-5p in the NPC cell line; K: Expression level of miR-980tp in NPC. Compared with the NP69 cell line, *P<0.05. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; FISH: fluorescence in situ hybridization; <t>DLR:</t> <t>dual-luciferase</t> reporter; RIP: RNA immunoprecipitation.
Dlr Gene Determination Kit, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dlr gene determination kit/product/Beijing Solarbio Science
Average 90 stars, based on 1 article reviews
dlr gene determination kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
dlr assay kit  (Yeasen Biotechnology)
90
Yeasen Biotechnology dlr assay kit
miR-98-5p is a target of CDKN2B-AS1. A: The common miRNA binding sites on CDKN2B-AS1 predicted by starBase and lncRBase; B: Subcellular localization of CDKN2B-AS1 detected by FISH assay (400×); C: miR-98-5p binding sites on CDKN2B-AS1; D: <t>DLR</t> assay results; E: RIP assay results; F: Expression levels of miR-98-5p in various tumors; G: Expression levels of miR-98-tp in the NPC tissues (n=38); H: ROC curve of miR-98-5p in the diagnosis of NPC; I: Correlation between the expression level of CDKN2B-AS1 and the expression level of miR-98-5p; J: Expression of miR-98-5p in the NPC cell line; K: Expression level of miR-980tp in NPC. Compared with the NP69 cell line, *P<0.05. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; FISH: fluorescence in situ hybridization; <t>DLR:</t> <t>dual-luciferase</t> reporter; RIP: RNA immunoprecipitation.
Dlr Assay Kit, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dlr assay kit/product/Yeasen Biotechnology
Average 90 stars, based on 1 article reviews
dlr assay kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
luciferase assay buffer ii dlr kit  (Promega)
90
Promega luciferase assay buffer ii dlr kit
miR-98-5p is a target of CDKN2B-AS1. A: The common miRNA binding sites on CDKN2B-AS1 predicted by starBase and lncRBase; B: Subcellular localization of CDKN2B-AS1 detected by FISH assay (400×); C: miR-98-5p binding sites on CDKN2B-AS1; D: <t>DLR</t> assay results; E: RIP assay results; F: Expression levels of miR-98-5p in various tumors; G: Expression levels of miR-98-tp in the NPC tissues (n=38); H: ROC curve of miR-98-5p in the diagnosis of NPC; I: Correlation between the expression level of CDKN2B-AS1 and the expression level of miR-98-5p; J: Expression of miR-98-5p in the NPC cell line; K: Expression level of miR-980tp in NPC. Compared with the NP69 cell line, *P<0.05. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; FISH: fluorescence in situ hybridization; <t>DLR:</t> <t>dual-luciferase</t> reporter; RIP: RNA immunoprecipitation.
Luciferase Assay Buffer Ii Dlr Kit, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/luciferase assay buffer ii dlr kit/product/Promega
Average 90 stars, based on 1 article reviews
luciferase assay buffer ii dlr kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
dlr detection kit  (Promega)
90
Promega dlr detection kit
miR-98-5p is a target of CDKN2B-AS1. A: The common miRNA binding sites on CDKN2B-AS1 predicted by starBase and lncRBase; B: Subcellular localization of CDKN2B-AS1 detected by FISH assay (400×); C: miR-98-5p binding sites on CDKN2B-AS1; D: <t>DLR</t> assay results; E: RIP assay results; F: Expression levels of miR-98-5p in various tumors; G: Expression levels of miR-98-tp in the NPC tissues (n=38); H: ROC curve of miR-98-5p in the diagnosis of NPC; I: Correlation between the expression level of CDKN2B-AS1 and the expression level of miR-98-5p; J: Expression of miR-98-5p in the NPC cell line; K: Expression level of miR-980tp in NPC. Compared with the NP69 cell line, *P<0.05. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; FISH: fluorescence in situ hybridization; <t>DLR:</t> <t>dual-luciferase</t> reporter; RIP: RNA immunoprecipitation.
Dlr Detection Kit, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dlr detection kit/product/Promega
Average 90 stars, based on 1 article reviews
dlr detection kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


miR-98-5p is a target of CDKN2B-AS1. A: The common miRNA binding sites on CDKN2B-AS1 predicted by starBase and lncRBase; B: Subcellular localization of CDKN2B-AS1 detected by FISH assay (400×); C: miR-98-5p binding sites on CDKN2B-AS1; D: DLR assay results; E: RIP assay results; F: Expression levels of miR-98-5p in various tumors; G: Expression levels of miR-98-tp in the NPC tissues (n=38); H: ROC curve of miR-98-5p in the diagnosis of NPC; I: Correlation between the expression level of CDKN2B-AS1 and the expression level of miR-98-5p; J: Expression of miR-98-5p in the NPC cell line; K: Expression level of miR-980tp in NPC. Compared with the NP69 cell line, *P<0.05. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; FISH: fluorescence in situ hybridization; DLR: dual-luciferase reporter; RIP: RNA immunoprecipitation.

Journal: American Journal of Translational Research

Article Title: CDKN2B-AS1 promotes the proliferation, clone formation, and invasion of nasopharyngeal carcinoma cells by regulating miR-98-5p/E2F2 axis

doi:

Figure Lengend Snippet: miR-98-5p is a target of CDKN2B-AS1. A: The common miRNA binding sites on CDKN2B-AS1 predicted by starBase and lncRBase; B: Subcellular localization of CDKN2B-AS1 detected by FISH assay (400×); C: miR-98-5p binding sites on CDKN2B-AS1; D: DLR assay results; E: RIP assay results; F: Expression levels of miR-98-5p in various tumors; G: Expression levels of miR-98-tp in the NPC tissues (n=38); H: ROC curve of miR-98-5p in the diagnosis of NPC; I: Correlation between the expression level of CDKN2B-AS1 and the expression level of miR-98-5p; J: Expression of miR-98-5p in the NPC cell line; K: Expression level of miR-980tp in NPC. Compared with the NP69 cell line, *P<0.05. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; FISH: fluorescence in situ hybridization; DLR: dual-luciferase reporter; RIP: RNA immunoprecipitation.

Article Snippet: At 48 h of transfection, the luciferase activity of the NPC cells was detected using the DLR assay kit (Solarbio Science & Technology, Beijing, China).

Techniques: Binding Assay, Expressing, Biomarker Discovery, Fluorescence, In Situ Hybridization, Luciferase, RNA Immunoprecipitation

CDKN2B-AS1 sponges miR-98-5p to upregulate E2F2 expression. A: Expression level of E2F2 in head and neck squamous cell carcinoma reported by UALCAN database; B: Expression level of E2F2 in NPC tissues (n=38); C: Effect of silencing CDKN2B-AS1 on E2F2 expression; D: Effect of miR-98-5p overexpression on E2F2; E: Effect of silencing both miR-98-5p and CDKN2B-AS1 on E2F2; F: Correlation of E2F2 expression level with miR-98-5p expression level in NPC; G: Correlation of E2F2 expression level with CDKN2B-AS1 expression level in NPC; H: miR-98-5p binding sites on E2F2; I: DLR assay results; J: RIP assay results. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; DLR: dual-luciferase reporter; RIP: RNA immunoprecipitation; E2F2: E2F transcription factor 2.

Journal: American Journal of Translational Research

Article Title: CDKN2B-AS1 promotes the proliferation, clone formation, and invasion of nasopharyngeal carcinoma cells by regulating miR-98-5p/E2F2 axis

doi:

Figure Lengend Snippet: CDKN2B-AS1 sponges miR-98-5p to upregulate E2F2 expression. A: Expression level of E2F2 in head and neck squamous cell carcinoma reported by UALCAN database; B: Expression level of E2F2 in NPC tissues (n=38); C: Effect of silencing CDKN2B-AS1 on E2F2 expression; D: Effect of miR-98-5p overexpression on E2F2; E: Effect of silencing both miR-98-5p and CDKN2B-AS1 on E2F2; F: Correlation of E2F2 expression level with miR-98-5p expression level in NPC; G: Correlation of E2F2 expression level with CDKN2B-AS1 expression level in NPC; H: miR-98-5p binding sites on E2F2; I: DLR assay results; J: RIP assay results. CDKN2B-AS1: CDKN2B antisense RNA 1; NPC: nasopharyngeal carcinoma; OD: optical density; DLR: dual-luciferase reporter; RIP: RNA immunoprecipitation; E2F2: E2F transcription factor 2.

Article Snippet: At 48 h of transfection, the luciferase activity of the NPC cells was detected using the DLR assay kit (Solarbio Science & Technology, Beijing, China).

Techniques: Expressing, Over Expression, Binding Assay, Luciferase, RNA Immunoprecipitation